A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Australasian journal of dermatology 2018-05, Vol.59 (2), p.147-148
Hauptverfasser: Maor, Danit, Brennand, Sarah, Goh, Michelle SY, Fahey, Vanessa, Tabrizi, Sepehr N, Chong, Alvin H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 148
container_issue 2
container_start_page 147
container_title Australasian journal of dermatology
container_volume 59
creator Maor, Danit
Brennand, Sarah
Goh, Michelle SY
Fahey, Vanessa
Tabrizi, Sepehr N
Chong, Alvin H
description
doi_str_mv 10.1111/ajd.12684
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2047371158</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2047371158</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3554-3f80f36fc5a33f9bb9397a92809dc37b995dc49bf0b65393565532d8b9e681d53</originalsourceid><addsrcrecordid>eNp10ctO3DAUBmCrKioD7aIvUFnqpiwCx3Gc2MsRBQaEBIu22-jEl9aj3LAT0LwKT4tnhrLDG1vWp986_gn5yuCUpXWGa3PK8lIWH8iCFQVkoEr4SBYAUGSSSzgkRzGuARhnQnwih7msmMwBFuR5STVGSwdHUT_MPlhD7eiNDd1gNnFsMXqkjzaEWXs3hM5H6nuKNNgeWzoF7Leon9KF9qO36aRbi8H3f-mTn_7Rbm4nn8J22uLUbYnvdTubrVnd_6E_rjCY9FB7Qh9Ra9_j5If-Mzlw2Eb75XU_Jr8vL36dr7Lbu6vr8-VtprkQRcadBMdLpwVy7lTTKK4qVLkEZTSvGqWE0YVqHDSl4IqLUgieG9koW0pmBD8m3_e5YxgeZhunej3MIU0X6xyKileMCZnUyV7pMMQYrKvH4DsMm5pBvW2hTi3UuxaS_faaODedNW_y_7cncLYHT761m_eT6uXNz33kC4bbk2Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2047371158</pqid></control><display><type>article</type><title>A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Maor, Danit ; Brennand, Sarah ; Goh, Michelle SY ; Fahey, Vanessa ; Tabrizi, Sepehr N ; Chong, Alvin H</creator><creatorcontrib>Maor, Danit ; Brennand, Sarah ; Goh, Michelle SY ; Fahey, Vanessa ; Tabrizi, Sepehr N ; Chong, Alvin H</creatorcontrib><identifier>ISSN: 0004-8380</identifier><identifier>EISSN: 1440-0960</identifier><identifier>DOI: 10.1111/ajd.12684</identifier><identifier>PMID: 28718200</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Acitretin - therapeutic use ; Adjuvants, Immunologic - therapeutic use ; Drug Therapy, Combination ; Epidermodysplasia verruciformis ; Epidermodysplasia Verruciformis - drug therapy ; Epidermodysplasia Verruciformis - etiology ; Female ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - therapeutic use ; Humans ; Imiquimod - therapeutic use ; Immunosuppression - adverse effects ; Keratolytic Agents - therapeutic use ; Kidney Transplantation ; Middle Aged ; Tretinoin - therapeutic use ; Vaccination</subject><ispartof>Australasian journal of dermatology, 2018-05, Vol.59 (2), p.147-148</ispartof><rights>2017 The Australasian College of Dermatologists</rights><rights>Copyright © 2018 The Australasian College of Dermatologists</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3554-3f80f36fc5a33f9bb9397a92809dc37b995dc49bf0b65393565532d8b9e681d53</citedby><cites>FETCH-LOGICAL-c3554-3f80f36fc5a33f9bb9397a92809dc37b995dc49bf0b65393565532d8b9e681d53</cites><orcidid>0000-0003-0652-8159</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajd.12684$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajd.12684$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28718200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maor, Danit</creatorcontrib><creatorcontrib>Brennand, Sarah</creatorcontrib><creatorcontrib>Goh, Michelle SY</creatorcontrib><creatorcontrib>Fahey, Vanessa</creatorcontrib><creatorcontrib>Tabrizi, Sepehr N</creatorcontrib><creatorcontrib>Chong, Alvin H</creatorcontrib><title>A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination</title><title>Australasian journal of dermatology</title><addtitle>Australas J Dermatol</addtitle><subject>Acitretin - therapeutic use</subject><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Epidermodysplasia verruciformis</subject><subject>Epidermodysplasia Verruciformis - drug therapy</subject><subject>Epidermodysplasia Verruciformis - etiology</subject><subject>Female</subject><subject>Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - therapeutic use</subject><subject>Humans</subject><subject>Imiquimod - therapeutic use</subject><subject>Immunosuppression - adverse effects</subject><subject>Keratolytic Agents - therapeutic use</subject><subject>Kidney Transplantation</subject><subject>Middle Aged</subject><subject>Tretinoin - therapeutic use</subject><subject>Vaccination</subject><issn>0004-8380</issn><issn>1440-0960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10ctO3DAUBmCrKioD7aIvUFnqpiwCx3Gc2MsRBQaEBIu22-jEl9aj3LAT0LwKT4tnhrLDG1vWp986_gn5yuCUpXWGa3PK8lIWH8iCFQVkoEr4SBYAUGSSSzgkRzGuARhnQnwih7msmMwBFuR5STVGSwdHUT_MPlhD7eiNDd1gNnFsMXqkjzaEWXs3hM5H6nuKNNgeWzoF7Leon9KF9qO36aRbi8H3f-mTn_7Rbm4nn8J22uLUbYnvdTubrVnd_6E_rjCY9FB7Qh9Ra9_j5If-Mzlw2Eb75XU_Jr8vL36dr7Lbu6vr8-VtprkQRcadBMdLpwVy7lTTKK4qVLkEZTSvGqWE0YVqHDSl4IqLUgieG9koW0pmBD8m3_e5YxgeZhunej3MIU0X6xyKileMCZnUyV7pMMQYrKvH4DsMm5pBvW2hTi3UuxaS_faaODedNW_y_7cncLYHT761m_eT6uXNz33kC4bbk2Y</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Maor, Danit</creator><creator>Brennand, Sarah</creator><creator>Goh, Michelle SY</creator><creator>Fahey, Vanessa</creator><creator>Tabrizi, Sepehr N</creator><creator>Chong, Alvin H</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0003-0652-8159</orcidid></search><sort><creationdate>201805</creationdate><title>A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination</title><author>Maor, Danit ; Brennand, Sarah ; Goh, Michelle SY ; Fahey, Vanessa ; Tabrizi, Sepehr N ; Chong, Alvin H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3554-3f80f36fc5a33f9bb9397a92809dc37b995dc49bf0b65393565532d8b9e681d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acitretin - therapeutic use</topic><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Epidermodysplasia verruciformis</topic><topic>Epidermodysplasia Verruciformis - drug therapy</topic><topic>Epidermodysplasia Verruciformis - etiology</topic><topic>Female</topic><topic>Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - therapeutic use</topic><topic>Humans</topic><topic>Imiquimod - therapeutic use</topic><topic>Immunosuppression - adverse effects</topic><topic>Keratolytic Agents - therapeutic use</topic><topic>Kidney Transplantation</topic><topic>Middle Aged</topic><topic>Tretinoin - therapeutic use</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maor, Danit</creatorcontrib><creatorcontrib>Brennand, Sarah</creatorcontrib><creatorcontrib>Goh, Michelle SY</creatorcontrib><creatorcontrib>Fahey, Vanessa</creatorcontrib><creatorcontrib>Tabrizi, Sepehr N</creatorcontrib><creatorcontrib>Chong, Alvin H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Australasian journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maor, Danit</au><au>Brennand, Sarah</au><au>Goh, Michelle SY</au><au>Fahey, Vanessa</au><au>Tabrizi, Sepehr N</au><au>Chong, Alvin H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination</atitle><jtitle>Australasian journal of dermatology</jtitle><addtitle>Australas J Dermatol</addtitle><date>2018-05</date><risdate>2018</risdate><volume>59</volume><issue>2</issue><spage>147</spage><epage>148</epage><pages>147-148</pages><issn>0004-8380</issn><eissn>1440-0960</eissn><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28718200</pmid><doi>10.1111/ajd.12684</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-0652-8159</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0004-8380
ispartof Australasian journal of dermatology, 2018-05, Vol.59 (2), p.147-148
issn 0004-8380
1440-0960
language eng
recordid cdi_proquest_journals_2047371158
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Acitretin - therapeutic use
Adjuvants, Immunologic - therapeutic use
Drug Therapy, Combination
Epidermodysplasia verruciformis
Epidermodysplasia Verruciformis - drug therapy
Epidermodysplasia Verruciformis - etiology
Female
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - therapeutic use
Humans
Imiquimod - therapeutic use
Immunosuppression - adverse effects
Keratolytic Agents - therapeutic use
Kidney Transplantation
Middle Aged
Tretinoin - therapeutic use
Vaccination
title A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T15%3A41%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20acquired%20epidermodysplasia%20verruciformis%20in%20a%20renal%20transplant%20recipient%20clearing%20with%20multimodal%20treatment%20including%20HPV%20(Gardasil)%20vaccination&rft.jtitle=Australasian%20journal%20of%20dermatology&rft.au=Maor,%20Danit&rft.date=2018-05&rft.volume=59&rft.issue=2&rft.spage=147&rft.epage=148&rft.pages=147-148&rft.issn=0004-8380&rft.eissn=1440-0960&rft_id=info:doi/10.1111/ajd.12684&rft_dat=%3Cproquest_cross%3E2047371158%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2047371158&rft_id=info:pmid/28718200&rfr_iscdi=true